Hib-DTP-hepatitis B vaccine - PT Bio Farma
Alternative Names: Pentabio vaccine; Pentavalent vaccine - PT Bio FarmaLatest Information Update: 14 Aug 2022
At a glance
- Originator PT Bio Farma
- Class Bacterial vaccines; Conjugate vaccines; Haemophilus vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
Most Recent Events
- 01 Aug 2022 PT Bio Farma in collaboration with Hasan Sadikin General Hospital plans a phase III trial for Diphtheria, Haemophilus infections, Pertussis, Tetanus, Hepatitis B,(Prevention, In Infants) in Indonesia (IM, Injection) in October 2022 (NCT05482282)
- 16 Dec 2021 PT Bio Farma completes a phase III trial for Diphtheria, Haemophilus infections, Hepatitis B, Pertussis, Tetanus (Prevention, In Infants) in Indonesia (IM) (NCT04071379)
- 13 Oct 2020 PT Bio Farma initiates a phase III trial for Diphtheria, Haemophilus infections, Hepatitis B, Pertussis, Tetanus (Prevention, In Infants) in Indonesia (IM) (NCT04071379)